Unlock instant, AI-driven research and patent intelligence for your innovation.

Aptamer sequence of hepatitis B virus (HBV) core antigen, and applications thereof

A technology of nucleic acid aptamer and hepatitis B virus, which can be applied in antiviral agents, pharmaceutical formulations, microbial measurement/testing, etc., and can solve the problems of nucleic acid aptamers, reports or publications of hepatitis B virus.

Active Publication Date: 2015-06-10
AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As far as hepatitis B virus is concerned, studies have reported peptide aptamers targeting the core antigen of hepatitis B virus, but so far there has been no report or publication of nucleic acid aptamers targeting hepatitis B virus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aptamer sequence of hepatitis B virus (HBV) core antigen, and applications thereof
  • Aptamer sequence of hepatitis B virus (HBV) core antigen, and applications thereof
  • Aptamer sequence of hepatitis B virus (HBV) core antigen, and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1: HBc gene cloning

[0026] Using known molecular cloning technology, based on the recombinant plasmid pBS_HBV3.6II containing double-copy HBV genome sequence, primers are designed according to the HBc gene sequence:

[0027] HBc_L: 5’-GCCCATATGGACATTGACCCGTA-3’

[0028] HBc_R: 5’-GCCCTCGAGTCAAACAACAGTAGTTT-3’

[0029] Configure PCR system (total volume 50ul): H 2 O 38ul, 10×PCR buffer 5ul, 25mM MgCl 2 3ul, dNTP (10mM) lul, primer mixture 1.5ul (H 2 O:100uM HBc_L:100uM HBc_R=4:0.5:0.5), 1ul DNA template, 0.5ul PrimeStar enzyme. Amplify on a PCR machine under the following conditions: after heating and pre-denaturing at 94°C for 2min, denaturation at 94°C for 30s, annealing at 55°C for 30s, extension at 72°C for 20s, 30 cycles, extension at 72°C for 8min, and incubation at 4°C for <1h.

[0030] After the reaction, 5ul of the product was electrophoresed in a 1% agarose gel at 100V at a constant pressure. After identifying and amplified DNA fragments that corresponded to t...

Embodiment 2

[0032] Example 2: HBc expression and purification

[0033] A single colony of E. coli containing the recombinant expression plasmid pET28a-HBc was inoculated into 5 mL of LB medium containing Kan antibiotics, and cultured overnight at 37°C. Transfer the overnight culture to 20OmL fresh medium according to the volume ratio of 1:100, and cultivate for 2~4h. 600 When the value reached 0.6, IPTG was added (final concentration is 0.1 mM) and induced and cultured at 30°C for 8 hours. The cells were collected by centrifugation at 4000 rpm for 30 min.

[0034] Resuspend the bacteria with 5mL lysis buffer (50mM Tris-HCl (pH8.5~9.0), 2mM EDTA, 100mM NaCl, 0.5% Triton X-100, 1mg / ml lysozyme), and divide them into 3 2ml tubes, -80 degrees for 30 minutes. 100w ultrasonic breaking in ice bath (2s~5s, 60~80 times). Take 1ml of supernatant and 500ul Ni-NTA Agarose beads and mix them, add to the purification column, use 2ml PBS+Mg(1mM MgCl 2 ) After washing twice, resuspend the mixture of protei...

Embodiment 3

[0036] Example 3: Nucleic acid aptamer screening (one round)

[0037] Sequence of the first round oligo DNA library:

[0038] 5’-acgctcggatgccactacagNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN NNNNctcatggacgtgctggtgac-3’

[0039] Primers used for enrichment:

[0040] Aptamer_L: 5’-FAM-acgctcggatgccactacag-3’

[0041] Aptamer_R: 5’-biotin-gtcaccagcacgtccatgag-3’

[0042] Determine the OD of the oligo DNA library 260 Afterwards, it was centrifuged to dry. Dissolve the library with 300ul PBS+Mg, take 200pmol (2.5nmol in the first round) at 95℃ for 8min, quickly place on ice, and then quickly centrifuge.

[0043] Reverse sieve: Aspirate 200pmol of the library into the reverse sieve target equivalent to 40pmol of the positive sieve target, and make up to 800ul with PBS+Mg. Shake at 37°C for 30 min. Suction the Milipore ultrafiltration tube and quickly centrifuge (<1000rpm), and take the filtrate.

[0044] Positive sieve: Take 40pmol positive sieve target, centrifuge at 800rpm, aspirate the supern...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the molecular immunity field, and relates to an aptamer sequence of an HBV core antigen, and uses thereof. A signature sequence TATTT having a specific binding HBV core antigen is prepared by adopting a gene recombinant plasmid to express the core antigen and screening an aptamer specially bound with the core antigen. The signature sequence is a base of the specific binding the aptamer and HBc, can be used for designing drugs and preparing drugs or other products, and the aptamer containing the signature sequence can be used for designing and preparing anti-HBV drugs or preparations as an anti-HBV probe or target spot.

Description

Technical field [0001] The invention belongs to the field of molecular immunity, and relates to a sequence of a nucleic acid aptamer of hepatitis B virus core antigen and its use. Background technique [0002] Hepatitis B (hepatitis B) is a major infectious disease that seriously endangers the health of our people. According to the World Health Organization (WHO), there are 130 million hepatitis B virus (hepatitis B virus, HBV) carriers and 30 million patients with liver disease in China every year. The death toll from various liver diseases reached 300,000. Liver disease has become one of the main diseases threatening the health of the Chinese population. The existence of a huge number of patients with chronic liver disease and the emergence of new cases of hepatitis each year have caused a great consumption of social medical resources. Studies have shown that hepatitis B virus is the main cause of hepatitis B, and the pathogen is clear. At present, the therapeutic effect of h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/115C12Q1/70C12Q1/68A61K48/00A61P31/20A61P1/16
Inventor 刘杰张骏
Owner AFFILIATED HUSN HOSPITAL OF FUDAN UNIV